🟢 BioCryst Pharmaceuticals is trading 4.58% up in after-hours trading — with no clear catalyst identified

BioCryst Pharmaceuticals is trading at $8.44, up 4.58% in after-hours trading, with no clear company-specific catalyst identified.

• No confirmed BioCryst announcement or other clear company-specific catalyst was found for October 13. The Scientific Advisory Board announcement was dated October 5 and does not establish the reason for the move.
• Broader indices were mixed, with the Nasdaq up 0.60%; that context does not clearly explain the individual move. The after-hours rise remains unexplained.